Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation

Pharmacopsychiatry

Volumn 42, Issue 5, 2009, Pages 194-201

  Wobrock, T ^a   Schneider Axmann, T ^a   Retz, W ^b   Rosler M ^b   Kadovic, D ^b   Falkai, P ^a   Schneider, M ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL SILENT PERIOD; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MOTOR CORTEX; MUSCLE EXCITATION; MUSCLE ISOMETRIC CONTRACTION; PRIORITY JOURNAL; RESTING MOTOR THRESHOLD; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; ANALYSIS OF VARIANCE; BRAIN; DRUG EFFECT; EFFERENT NERVE; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; HAND; INNERVATION; MUSCLE CONTRACTION; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TIME;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BRAIN; EFFERENT PATHWAYS; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HAND; HUMANS; MALE; MOTOR CORTEX; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEURAL INHIBITION; SCHIZOPHRENIA; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 70350453795     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1224137     Document Type: Article

References (44)

1. Adler LE, Pachtman E, Frank RD, etal. Neuophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry 1982 17 639-654
2. Annett M. A classification of hand preference by association analysis. Br J Psychol 1970 61 303-321
3. Bajbouj M, Gallinat J, Niehaus L, etal. Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia. Pharmacopsychiatry 2004 37 74-80
4. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985 1 1106-1107
5. Bassett AS, Collins EJ, Nuttall SE, etal. Positive and negative symptoms in families with schizophrenia. Schizophr Res 1993 11 9-19
6. Beauregard M, Ferron A. Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an iontophoretic study. Eur J Pharmacol 1991 205 225-231
7. Cantello R, Gianelli M, Civardi C, etal. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992 42 1951-1959
8. Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 2002 38 309-327 (Pubitemid 34219109)
9. Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenia patients and their nonpsychotic siblings. J Nerv Ment Dis 2000 188 84-89
10. Daskalakis ZJ, Christensen BK, Chen R, etal. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002 59 347-354
11. Daskalakis ZJ, Christensen BK, Chen R, etal. Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berl) 2003 170 255-262
12. Davey NJ, Puri BK, Lewis HS, etal. Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia. J Neurol Neurosurg Psychiatry 1997 63 468-473
13. Day BL, Dressler D, Maertens De Noordhout A, etal. Electrical and magnetic stimulation of human motor cortex: surface EMG and single motor-unit responses. J Physiol (Lond) 1989 412 449-473
14. Di Lazarro V, Oliviero A, Profice P, etal. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003 547 485-496
15. Endicott J, Spitzer RL, Fleiss JL, etal. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976 33 766-771
16. Fitzgerald PB, Brown TL, Daskalakis ZJ, etal. A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia. Psychopharmacology (Berl) 2002 162 74-81
17. Fitzgerald PB, Brown TL, Daskalakis ZJ, etal. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res 2002 114 11-22
18. Fitzgerald PB, Brown TL, Daskalakis ZJ, etal. A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation. Schizophr Res 2002 56 199-209
19. Fitzgerald PB, Brown TL, Marston NA, etal. Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study. Schizophr Res 2004 71 17-26
20. Freedman R, Adler LE, Waldo MC, etal. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry 1983 18 537-551
21. Fydrich T, Renneberg B, Schmitz B, etal. Strukturiertes Klinisches Interview für DSM-IV. Achse II: Persönlichkeitsstörungen. A German, advanced adaptation of the original SCID version by RL. Spitzer, JB. Williams, M. Gibbon and MB First. Göttingen: Hogrefe 1997
22. Guy W, Bonato RR. editors CGI: Clinical Global Impressions. In: Manual for the ECDEU Assessment Battery.2. Rev ed Md: National Institute of Mental Health: Chevy Chase 1976 p. 12/1-12/6
23. Hommel G. A comparison of two modified Bonferroni procedures. Biometrika 1988 75 383-386
24. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987 13 261-276
25. Langguth B, Eichhammer P, Spranz C, etal. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology 2008 196 623-629
26. Liepert J, Restemeyer C, Kucinski T, etal. Motor strokes: the lesion location determines motor excitability changes. Stroke 2005 36 2648-2653
27. Maeda F, Pascual-Leone A. Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders. Psychopharmacology 2003 168 359-376
28. Moll GH, Heinrich H, Trott GE, etal. Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system. Ann Neurol 2001 49 393-396
29. Puri BK, Davey NJ, Ellaway PH, etal. An investigation of motor function in schizophrenia using transcranial magneticstimulation of the motor cortex. Br J Psychiatry 1996 169 690-695
30. Saka MC, Atbasoglu EC, Ozguven HD, etal. Cortical inhibition in first-degree relatives of schizophrenia patients assessed with transcranial magnetic stimulation. Int J Neuropsychopharmacol 2005 7 1-5
31. Seeman P, Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc Natl Acad Sci USA 2000 97 8104-8109
32. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986 73 751-754
33. Smith RC, Hussain MI, Chowdhury SA, etal. Stability of neurological soft signs in chronically hospitalised schizophrenia patients. J Neuropsychiatry Clin Neurosci 1999 11 91-96
34. Vogels TP, Abbott LF. Gating deficits in model networks: a path to schizophrenia? Pharmacopsychiatry 2007 40 (Suppl. 1) S73-S77
35. Werhahn KJ, Kunesch E, Noachtar S, etal. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond) 1999 517 501-507
36. Winterer G. Prefrontal dopamine signalling in schizophrenia the corticocentric model. Pharmacopsychiatry 2007 40 (Suppl 1) S45-S53
37. Wittchen HU, Wunderlich U, Gruschwitz S, etal. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. A German, advanced adaptation of the original SCID version by RL. Spitzer, JB. Williams, M. Gibbon and MB. First Göttingen: Hogrefe 1997
38. Wobrock T, Kadovic D, Falkai P. Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation. Nervenarzt 2007 78 753-754 756-763
39. Wobrock T, Schneider M, Kadovic D, etal. Reduced cortical inhibition in first-episode schizophrenia. Schizophr Res 2008 Jul 12 [Epub ahead of print]
40. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003 64 663-667
41. Ziemann U, Netz J, Szelenyi A, etal. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993 156 167-171
42. Ziemann U, Lonnecker S, Steinhoff BJ, etal. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996 40 367-378
43. Ziemann U, Tergau F, Bruns D, etal. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997 105 430-437
44. Ziemann U. TMS and drugs. Clin Neurophysiol 2004 115 1717-1729